For the year ending 2025-12-31, WVE has $638,499K in assets. $112,268K in debts. $602,068K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 602,068 | |||
| Accounts receivable | 1,276 | |||
| Prepaid expenses | 8,395 | |||
| Other current assets | 3,075 | |||
| Total current assets | 614,814 | |||
| Property and equipment gross | 56,927 | |||
| Less accumulated depreciation | 49,522 | |||
| Property and equipment, net of accumulated depreciation of 49,522 and 46,329 as of december 31, 2025 and 2024 respectively | 7,405 | |||
| Operating lease right-of-use assets | 12,458 | |||
| Restricted cash | 3,806 | |||
| Other assets | 16 | |||
| Total long-term assets | 23,685 | |||
| Total assets | 638,499 | |||
| Accounts payable | 15,700 | |||
| Accrued expenses and other current liabilities | 26,564 | |||
| Current portion of deferred revenue | 44,440 | |||
| Current portion of operating lease liability | 8,361 | |||
| Total current liabilities | 95,065 | |||
| Deferred revenue, net of current portion | 7,798 | |||
| Operating lease liability, net of current portion | 9,405 | |||
| Total long-term liabilities | 17,203 | |||
| Total liabilities | 112,268 | |||
| Series a preferred shares, no par value 3,901,348 shares issued and outstanding at december 31, 2025 and 2024 | 7,874 | |||
| Ordinary shares, no par value 187,660,263 and 153,037,286 shares issued and outstanding at december 31, 2025 and 2024, respectively | 1,616,478 | |||
| Additional paid-in capital | 228,365 | |||
| Accumulated other comprehensive loss | -250 | |||
| Accumulated deficit | -1,326,236 | |||
| Total shareholders' equity | 518,357 | |||
| Total liabilities, series a preferred shares and shareholders' equity | 638,499 | |||
Wave Life Sciences Ltd. (WVE)
Wave Life Sciences Ltd. (WVE)